Study confirms the benefits of 'bridge therapy' for some children with high-risk neuroblastoma
New findings published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society, show that a "bridge therapy" between induction and consolidation treatments may benefit patients with this high-risk neuroblastoma.